Trial Profile
A Phase I Study of Oral PHA-848125AC Given Daily For 7 Consecutive Days Every 2 Weeks or for 4 Consecutive Days A Week for 3 Consecutive Weeks Every 4 Weeks to Adult Patients With Advanced/Metastatic Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Mar 2011
Price :
$35
*
At a glance
- Drugs Milciclib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 01 Mar 2011 New trial record